Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.86 |
| ▸ | LMNA | P02545 | 3/20 | 0.86 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.86 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.86 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.67 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.67 |
| ▸ | PPARG | P37231 | 7/20 | 0.63 |
| ▸ | PPARD | Q03181 | 7/20 | 0.63 |
| ▸ | PPARA | Q07869 | 7/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.63 |
| ▸ | TLR2 | O60603 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL7059164 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Sebacic Acid SCHEMBL7053731 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Ethylene SCHEMBL7053999 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Ethylene SCHEMBL7053736 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Sebacic Acid SCHEMBL7058067 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Ethylene SCHEMBL873940 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Ethylene SCHEMBL7060522 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Sebacic Acid SCHEMBL586054 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Sebacic Acid SCHEMBL7053993 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 | |
| Azelaic Acid SCHEMBL2484376 | 1.00 | TSHR (0.86) | TSHRLMNANFKB1PMP22GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119300547-A | Photovoltaic cover plate and photovoltaic module | 苏州阿特斯阳光电力科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-114269834-A | Use of a composition for producing foamed articles | SABIC环球技术有限责任公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113439766-A | Repellent for animals in airports and preparation method thereof | 章荣彬 | 2021-09-28 | — | — | CN | claimed |
| CN-113073006-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2021-07-06 | — | — | CN | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| CN-114846002-B | Substituted 4-methylene-tetrahydropyrans, 4-methyl-dihydropyrans and 4-methyl-tetrahydropyrans and their use as fragrance chemicals | 巴斯夫欧洲公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-113015716-B | Acetate compounds useful as flavoring agents | 奇华顿股份有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-113286776-B | Bicyclic and tricyclic compounds useful as fragrance chemicals | 巴斯夫欧洲公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118185186-A | Polymer composition | SABIC环球技术有限责任公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-112469689-B | Alpha, alpha-disubstituted carboxylic acid esters useful as fragrance chemicals | 巴斯夫欧洲公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-114269834-B | Use of a composition for producing foamed articles | SABIC环球技术有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-105431510-B | Organic compounds | 奇华顿股份有限公司 | 2020-02-11 | — | — | CN | disclosed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | disclosed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | disclosed |
| US-6458972-B1 | THERMAL CLEAVAGE OF MACROCYCLIC ESTERS IN THE PRESENCE OF A THERMOSTABLE BENZENE DERIVATIVE | HAARMANN & REIMER GMBH (DE) | 2002-10-01 | — | — | US | disclosed |
| US-20020095045-A1 | Process for the preparation of macrocyclic esters | SYMRISE GMBH & CO., KG (DE) | 2002-07-18 | — | — | US | disclosed |
| US-6034052-A | CONTAINING DIESTERS | HAARMANN & REIMER GMBH (DE) | 2000-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | TSHR 4206/4885LMNA 2101/4885NFKB1 848/4885 |
| US-20020095045-A1 | Process for the preparation of macrocyclic esters | CYP3A4, CYP4A11, CASP14 | TSHR 3176/4885LMNA 503/4885NFKB1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.